NR2B Selective NMDA Receptor Antagonist CP-101,606 Prevents Levodopa-Induced Motor Response Alterations in Hemiparkinsonian Rats

R. H. Wessell, Justin Do-hoon Oh-Lee, Gary Dunbar

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)184-194
JournalNeuropharmacology
Volume47
StatePublished - 2004

Fingerprint

Dive into the research topics of 'NR2B Selective NMDA Receptor Antagonist CP-101,606 Prevents Levodopa-Induced Motor Response Alterations in Hemiparkinsonian Rats'. Together they form a unique fingerprint.

Cite this